Solvotrin Therapeutics Overview

  • Founded
  • 2009
Founded
  • Status
  • Private
  • Employees
  • 20
Employees
  • Latest Deal Type
  • Later Stage VC
  • Latest Deal Amount
  • $11.8M
Latest Deal Amount
  • Investors
  • 7

Solvotrin Therapeutics General Information

Description

Developer of a drug development platform designed to focus on developing drugs for the cardiovascular market. The company's platform develops drugs with the focus on optimizing established therapies, vitamins and minerals which help in the management of iron deficiency and gastric problems associated with traditional aspirin, enabling clients to get more effective medicines.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Primary Office
  • Hoffmann Park, Little Island
  • Cork
  • Ireland
+353 (021) 000 0000

Solvotrin Therapeutics Timeline

2017201820192020
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Solvotrin Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Later Stage VC 08-Jun-2018 $11.8M 0000 Completed Generating Revenue
4. Later Stage VC 01-Jan-2018 00000 00.00 Completed Generating Revenue
3. Later Stage VC 01-Jan-2017 00.000 00.000 Completed Generating Revenue
2. Grant 13-Nov-2012 $68.1K $4.81M Completed Startup
1. Early Stage VC 01-Jul-2011 $4.81M $4.81M Completed Startup
To view Solvotrin Therapeutics’s complete valuation and funding history, request access »

Solvotrin Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of a drug development platform designed to focus on developing drugs for the cardiovascular market. The compan
Drug Discovery
Cork, Ireland
20 As of 2019
0000
0000000000 0 0000

0000000

nim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequ
000000000000000
East Rutherford, NJ
0000 As of 0000
0.00 0000-00-00
000000000000

0000000

cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culp
000000000000000
Lugano, Switzerland
000 As of 0000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Solvotrin Therapeutics Competitors (8)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Cambrex Private Equity-Backed East Rutherford, NJ 0000 000000000000
0000000 0000000000 Corporation Lugano, Switzerland 000
000000000000000 Corporation Brentford, United Kingdom 00000 00000000000
00000 & 00. Corporation Kenilworth, NJ 00000 00000000
000000 Corporation New York, NY 00000 000000 - 000
You’re viewing 5 of 8 competitors. Get the full list »

Solvotrin Therapeutics Executive Team (5)

Name Title Board Seat Contact Info
Pat O'Flynn Co-Founder, Chief Executive Officer and President
George Walsh Chief Financial Officer
Mark Ledwidge Ph.D Co-Founder & Vice President, Development & Strategy
John Gilmer Vice President, Research & Development & Co-Founder
Peter Caldini Chairman
To view Solvotrin Therapeutics’s complete executive team members history, request access »

Solvotrin Therapeutics Board Members (2)

Name Representing Role Since
Diarmuid Burke Solvotrin Therapeutics Board Member 000 0000
Peter Caldini Solvotrin Therapeutics Chairman 000 0000
To view Solvotrin Therapeutics’s complete board members history, request access »

Solvotrin Therapeutics Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Solvotrin Therapeutics Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Anne Heraty Angel (individual) Minority 000 0000 000000 0
David Power Angel (individual) Minority 000 0000 000000 0
Ergo Corporation Minority 000 0000 000000 0
Healy Chemicals Limited Corporation Minority 000 0000 000000 0
InterTradeIreland Corporation 000 0000 000000 0
You’re viewing 5 of 7 investors. Get the full list »